Home › Pricey successor overtakes $1,000-per-pill hepatitis C drug
 

Keywords :   


Pricey successor overtakes $1,000-per-pill hepatitis C drug

2015-07-13 10:00:43| Biotech - Topix.net

Harvoni, the newest pill from California-based Gilead Sciences, accounted for more than three-fourths of the prescriptions ... . This image provided by Gilead Sciences shows a bottle of the Hepititis drug Harvoni.

Tags: drug successor hepatitis pricey

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.05Visitor Registration Open for Coatings for Africa
07.05OQ Chemicals Resumes Operations in German Plants
07.05Polychem Powder Coatings Moves into New Production Facility
07.05Cyngientappoints Jake Chaney VP of sales
07.05Printing United Alliance launches new iLEARNING+ courses
07.05Huggies Launches Skin Essentials Diaper
07.05Meisheng Starts Up Needlepunch Line
07.05Clemens Food Group expands pork production with Kunzler acquisition
More »